retatrutide weight loss clinical trials results produces up to 30.3% in Phase 3 trial VisualAbstract: Retatrutide reduces body weight

PubMed Coskun T, et al

The convenience factor should not be underestimated

But contact your provider if you experience severe or persistent pain at the injection site lasting more than 48 hours, signs of infection such as increasing redness, warmth, swelling, or pus, severe nausea or vomiting that prevents you from keeping fluids down, or any symptoms that feel significantly different from your normal semaglutide experience

Semaglutide offers proven safety, pharmaceutical access, cardiovascular data, and good tolerability with meaningful weight loss

Robinson has been regularly profiled and featured as an expert in major media outlets, including Bloomberg News, Forbes, The Wall Street Journal, INSIDER, VICE, The Miami Herald, Authority Magazine, Thrive Global, Benzinga, and others

View Our Interactive Dashboard on GLP-1RA Therapies in Development (Free Excel Available) Pfizer, Novo work on oral GLP-1 RAs